Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Funds / Archimed MED IV

Archimed MED IV

Unknownbuyout or unlabelledArchimed
Amounts, each with its basis
Vintage
unknownno dated first sale, first report or announcement yet
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
unknownwhat may be sold, not what was raised
Form D sold
unknownno Form D on record
First sale
unknown
Reported gross assets
unknownForm ADV; not fund size, not dry powder
Peak reported gross assets
unknownhighest year on the reporting tape
Owners (ADV)
unknown
Reported on ADV
unknown
Lifecycle
Unknown
model: lc-pe-1missing: fewer than two reported years of gross asset valuegav path: as of year: n/areported years: 0first reported year: n/a
Reported gross assets by year
0 annual rows
No Form ADV reporting row for this fund. It may be known from Form D only.
Placement agents and principals
0 placement agents, 0 principals
No placement agent or principal collected for this fund yet. Both come from the related persons and sales compensation sections of Form D.
Limited partners
0 disclosed
No LP commitment to this fund collected yet. An LP appears only when a public disclosure names this fund.
Investments attributed to this fund
0
No investment attributed to this fund. A firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Events
1 most recent
  1. Sep 9, 2026
    ARCHIMED closes MED IV fund at €1.5 billion ($1.75 billion) hard cap, three times oversubscribed, in less than six months of fundraising.
    Fund final close Fact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)